White label ELPA - ClinicalTrials.eu

Study on Ertugliflozin for Children and Teens with Type 2 Diabetes

Not recruiting

3 1
Investigated diseases:
- Type 2 diabetes mellitus
Investigated drugs:
- Ertugliflozin
Study on the Safety and Effects of MBF-118 for Crohn’s Disease Patients with Stenosis

Not recruiting

2 1 1
Investigated diseases:
- Crohn’s disease
Investigated drugs:
- Mbf-118
Study of Tolinapant with Decitabine and Cedazuridine for Patients with Relapsed or Refractory Peripheral T-cell Lymphoma

Not recruiting

1 1 1
Investigated diseases:
- T-cell lymphoma
Investigated drugs:
Study on the Safety and Effects of PBF-999 for Patients with Prader-Willi Syndrome

Not recruiting

2 1
Investigated diseases:
- Prader-Willi syndrome
Investigated drugs:
- Pbf-999
Study of Ezurpimtrostat with Atezolizumab and Bevacizumab for Patients with Unresectable Liver Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Hepatocellular carcinoma
Investigated drugs:
Study on the Long-Term Safety and Effectiveness of Minzasolmin and Iodine Ioflupane (123I) in Patients with Parkinson’s Disease

Not recruiting

2 1 1
Investigated diseases:
- Parkinson’s disease
Investigated drugs:
- Ioflupane (123I)
- Minzasolmin
Study of Pembrolizumab and Cisplatin for Patients with Stage III-IVA Resectable Head and Neck Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Squamous cell carcinoma of head and neck
Investigated drugs:
- Pembrolizumab
- Cisplatin
+3
Study on the Effect of a New Moisturiser with Paraffin and Liquid Paraffin on Preventing Eczema Relapse in Children

Not recruiting

3 1 1 1
Investigated diseases:
- Eczema
- Dermatitis atopic
Investigated drugs:
Study to Compare Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Not recruiting

3 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
+5
Study on Upadacitinib for Adults with Active Axial Spondyloarthritis

Not recruiting

3 1
Investigated diseases:
- Ankylosing spondylitis
- Axial spondyloarthritis
Investigated drugs:
- Abt-494
+3

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies